查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2006251

C型臂市場：依系統類型、檢測器類型、技術、應用和最終用戶分類－2026-2032年全球市場預測

C-arms Market by System Type, Detector Type, Technology, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，C 型臂市場價值將達到 27.9 億美元，到 2026 年將成長到 30.4 億美元，到 2032 年將達到 50.2 億美元，複合年成長率為 8.76%。

主要市場統計數據
基準年 2025 27.9億美元
預計年份：2026年 30.4億美元
預測年份 2032 50.2億美元
複合年成長率 (%) 8.76%

詳細說明最新的 C 型臂技術、臨床效用、採用因素以及影響 C 型臂在醫療機構中引入的營運重點。

C型臂影像平台在眾多介入專科領域持續發揮核心作用，可在微創手術中實現即時螢光成像。這些系統部署於醫院手術室、混合手術室和門診手術室，其在器械引導、定位驗證和減少手術併發症的功能構成了現代臨床工作流程的基礎。隨著微創手術在臨床路徑中日益重要，對可靠、高解析度影像的需求也日益成長，這種影像方式能夠簡化手術流程並與電子健康記錄無縫整合。

這顯然整合了技術進步、軟體整合和操作變革，從根本上重新定義了 C 型臂系統的規格製定、採購和支援方式。

C型臂產業正經歷一系列變革，這些變革正在重新定義產品藍圖和臨床預期。檢測器技術和影像處理技術的進步提高了影像品質和低劑量性能，使得在以往缺乏高階影像支援的環境中開展更複雜的手術成為可能。同時，模組化和小型化使得行動系統在許多應用情境下能夠達到與固定安裝系統相媲美的效能，從而實現了更靈活的部署模式，更能適應不斷變化的醫療服務模式。

對 2025 年關稅變化如何重組整個 C-ARM 生態系統的供應鏈、採購計畫和籌資策略進行全面檢驗。

美國2025年實施的貿易政策調整和關稅措施引發了各行各業的多方面反應，從採購決策到臨床環境中的採購時間表均受到影響。部分進口零件關稅的提高迫使原始設備製造商（OEM）重新評估其全球供應鏈，加速了關於擴大近岸外包、多源採購和本地組裝的討論，以維持價格競爭力並降低前置作業時間風險。因此，採購團隊調整了資本規劃中的緩衝資金，並尋求提高零件來源和供應商韌性方面的透明度。

針對特定領域的情報，解讀應用、系統類型、檢測器配置、最終用戶購買模式以及從類比技術過渡到數位技術的趨勢。

細分市場層面的趨勢揭示了不同的需求模式，這些模式有助於產品設計、銷售策略和臨床定位。臨床需求因應用領域而異。在心血管外科手術中，高時間解析度和穩定的透視性能對於血管導航至關重要；而在胃腸病學和泌尿系統中，則需要具有靈活C臂角度調節功能的緊湊型系統來適應內視鏡手術流程。在整形外科和疼痛管理領域，影像清晰度是骨骼和植入清晰顯示的首要考慮因素；而在血管外科手術中，則需要廣角成像和先進的對比控制。這些應用領域驅動的差異會影響功能優先順序、培訓要求和服務合約。

從區域觀點解釋法規環境、基礎設施成熟度和本地生產能力如何影響全球市場對 C 型臂的採用。

區域趨勢影響著科技的應用路徑和商業策略，法律規範、醫療服務模式和製造地等方面的差異是造成這種差異的原因。在美洲，臨床需求集中在大規模醫院網路和快速發展的門診手術中心，這得益於成熟的分銷管道和對生命週期服務合約的高度重視。該地區的報銷框架和資本核准流程正在推動投資，從而提高營運效率並帶來可衡量的臨床改善，進而促使人們對整合成像和軟體功能產生更大的興趣。

企業層面的策略分析，說明了決定供應商競爭優勢的產品模組化、服務差異化、夥伴關係策略和不斷演變的商業模式。

領先供應商的企業策略強調端到端的價值提案，將硬體、軟體和服務結合。各公司正投資於模組化產品架構，以便適應未來的檢測器升級和軟體增強，從而延長儀器的使用壽命，並透過維護和軟體授權獲得持續的收入。與導航、機器人和分析服務提供者的策略合作也日益普遍，從而實現能夠應對複雜手術流程並創造差異化臨床價值的整合解決方案。

供應商和醫療保健系統可採取的策略重點，以加強供應鏈韌性、加速技術轉型以及實現服務和軟體能力的貨幣化。

產業領導企業應優先考慮幾項策略性舉措，以鞏固市場地位並加速臨床應用。首先，他們需要透過多元化採購和區域組裝系統來增強供應鏈韌性，從而降低貿易和關稅波動帶來的風險。此外，還應結合透明的供應商資訊和合約條款，以減少前置作業時間和成本的不確定性。其次，他們應加快向平板檢測器技術和軟體功能的轉型，這些技術和功能能夠顯著提高影像品質和劑量效率，同時透過為現有部署提供改裝方案來維護客戶關係。

為了檢驗可靠的研究結果，我們採用了一種透明、嚴謹的混合方法研究途徑，將對臨床醫生和採購負責人的初步訪談與法規和技術方面的二手資訊的三角檢驗相結合。

本研究途徑結合了定性和定量方法，以確保獲得全面且經得起驗證的見解。主要研究包括對介入檢驗、放射科負責人、手術室經理、採購負責人以及涵蓋各類急診和門診機構的服務部門主管進行結構化訪談和引導式討論​​。這些對話探討了臨床需求、採購標準、服務期望和實際使用模式，並將技術和商業性的觀察結果與實際經驗相結合。

簡明扼要地總結了 C 型臂領域的技術進步、供應鏈現狀以及供應商和醫療機構面臨的策略挑戰。

總而言之，C型臂系統處於臨床需求、技術創新和營運限制的交匯點。檢測器現代化、軟體整合以及採購模式的轉變正在重塑醫療系統和門診機構評估影像平台的方式。收費系統驅動的供應鏈變化凸顯了製造彈性和採購透明度的必要性，而法規和基礎設施的區域差異則要求制定本地化的商業化策略。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：C型臂市場依系統類型分類

  • 固定的
  • 活動

第9章：檢測器類型分類的C型臂市場

  • 平板檢測器
  • 影像增強器
    • 12英吋
    • 16英寸
    • 9吋

第10章：C型臂市場：依技術分類

  • 模擬
  • 數位的

第11章 C型臂市場：按應用領域分類

  • 循環系統
  • 緊急狀況
  • 胃腸病學
  • 整形外科
  • 疼痛管理
  • 泌尿系統
  • 血管外科

第12章 C型臂市場：依最終用戶分類

  • 門診手術中心
  • 醫院

第13章 C型臂市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 C型臂市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 C型臂市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國C型臂市場

第17章：中國C臂市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Airbus SE
  • Aviation Industry Corporation of China, Ltd.
  • BAE Systems plc
  • China Aerospace Science and Industry Corporation Limited
  • China Electronics Technology Group Corporation
  • China North Industries Group Corporation Limited
  • China State Shipbuilding Corporation Limited
  • General Dynamics Corporation
  • General Electric Company
  • L3Harris Technologies, Inc.
  • Leonardo SpA
  • Lockheed Martin Corporation
  • Mitsubishi Heavy Industries, Ltd.
  • Northrop Grumman Corporation
  • Rheinmetall AG
  • RTX Corporation
  • Saab AB
  • State Corporation Rostec
  • Thales Group（Thales SA）
  • The Boeing Company
Product Code: MRR-B1685377A596

The C-arms Market was valued at USD 2.79 billion in 2025 and is projected to grow to USD 3.04 billion in 2026, with a CAGR of 8.76%, reaching USD 5.02 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.79 billion
Estimated Year [2026] USD 3.04 billion
Forecast Year [2032] USD 5.02 billion
CAGR (%) 8.76%

An informed introduction to contemporary C-arm technology, clinical utility, procurement drivers, and operational priorities that shape adoption across care settings

C-arm imaging platforms remain central to a wide range of interventional specialties, enabling real-time fluoroscopic visualization during minimally invasive procedures. These systems are deployed across hospital operating rooms, hybrid suites, and outpatient surgical settings where their ability to guide instrumentation, confirm placement, and reduce procedural complications has become foundational to modern clinical workflows. As clinical pathways increasingly favor minimally invasive approaches, demand for dependable, high-resolution imaging that integrates seamlessly into procedure ergonomics and electronic health records has intensified.

Technological evolution has shifted vendor focus from analogue image intensifiers toward digital flat panel detectors, improved dose management, and software-driven image processing. Meanwhile, serviceability, total cost of ownership, and lifecycle support are prominent considerations for procurement teams constrained by capital planning cycles and clinical throughput requirements. Regulatory oversight and procurement protocols vary by geography, shaping adoption rhythms and vendor go-to-market models. In this context, clarity around application-specific requirements, system form factor choices, and detector technology trade-offs is essential for clinical leaders and business executives alike to align technology investments with patient outcomes and operational efficiency goals.

A clear synthesis of technology advancements, software integration, and operational shifts that are fundamentally redefining how C-arm systems are specified, purchased, and supported

The C-arm landscape is experiencing a suite of concurrent transformative shifts that are redefining product road maps and clinical expectations. Advances in detector technology and image processing have pushed image quality and low-dose performance forward, enabling more complex procedures in settings that previously lacked high-end imaging support. At the same time, modularity and miniaturization have allowed mobile systems to gain functional parity with fixed installations for many use cases, enabling flexible deployment models that better align with evolving care delivery patterns.

Software is now a strategic differentiator: integration with navigation, robotics, and AI-enabled image enhancement is expanding the clinical envelope and creating new value streams tied to recurring software licenses and service agreements. In parallel, hospital planning increasingly emphasizes hybrid operating rooms that blend imaging and interventional capability, which drives demand for systems designed for interoperability and sterility management. Operational considerations such as uptime, remote diagnostics, and optimized service logistics are rising in importance, particularly as providers seek to protect clinical throughput and reduce unplanned capital expenditure. Consequently, manufacturers and service providers are adapting to a landscape where hardware excellence must be paired with robust software ecosystems, flexible financing models, and resilient supply chains.

A comprehensive examination of how tariff changes in 2025 reshaped supply chains, procurement timelines, and sourcing strategies across the C-arm ecosystem

Trade policy adjustments and tariff implementations in the United States during 2025 have generated a multifaceted industry response that extends from sourcing decisions to clinical procurement timing. Increased duties on certain imported components have pressured original equipment manufacturers to re-evaluate global supply chains, accelerating conversations about nearshoring, multi-sourcing, and increased local assembly to preserve price competitiveness and mitigate lead-time risk. As a result, procurement teams have adjusted capital planning buffers and sought greater transparency around component provenance and supplier resilience.

Vendors have reacted by shifting manufacturing footprints, renegotiating supplier contracts, and optimizing bills of materials to reduce exposure to tariffed inputs. These changes have incentivized design-for-manufacturing and supplier consolidation strategies that favor components with stable trade classifications. Meanwhile, distributors and service providers are recalibrating stocking policies and spare parts inventories to avoid service disruptions that could compromise operating room schedules. Clinical and procurement leaders are prioritizing systems with predictable maintenance models and strong service networks to prevent throughput erosion.

Regulatory compliance and import documentation now factor more prominently into total procurement timelines, especially for complex purchases requiring multi-site approvals. The cumulative operational effect includes extended evaluation periods and a heightened emphasis on contractual protections around price adjustments and lead times. In this environment, institutions that proactively engage with suppliers on supply chain transparency and lifecycle support can better safeguard clinical continuity and capital efficiency.

Segment-specific intelligence that decodes application, system type, detector configurations, end-user purchasing patterns, and analog-to-digital technology adoption dynamics

Segment-level dynamics reveal differentiated demand patterns that inform product design, sales strategy, and clinical positioning. Based on application, clinical needs vary markedly: cardiology procedures emphasize high temporal resolution and consistent fluoroscopic performance for vascular navigation, whereas gastroenterology and urology require compact systems with flexible C-arm angulation to accommodate endoscopic workflows. Orthopedics and pain management prioritize image clarity for bone and implant visualization, and vascular surgery demands extended field-of-view imaging and advanced contrast management. These application-driven distinctions influence feature prioritization, training requirements, and service contracts.

Based on system type, procurement choices are driven by the trade-off between the stability and higher throughput of fixed installations and the flexibility and lower footprint of mobile units. Facilities with multiple procedure types or constrained capital budgets tend to favor mobile systems that can be redeployed across rooms, while high-volume interventional centers and hybrid ORs typically specify fixed platforms for integrated sterility and imaging performance.

Based on detector type, there is a clear technical divergence between flat panel detectors and image intensifiers. Flat panel detectors are increasingly preferred for their uniform image quality, lower distortion, and improved dose efficiency, but image intensifiers remain relevant in specific legacy fleets and cost-sensitive deployments. Within the image intensifier category, preferences for 12 inch, 16 inch, or 9 inch formats depend on procedure types and field-of-view requirements, with larger intensifiers serving broader anatomical coverage and smaller formats supporting targeted interventions.

Based on end user, ambulatory surgical centers and hospitals present different purchasing profiles: ambulatory centers prioritize throughput, rapid turnaround, and capital efficiency, while hospitals emphasize integration, redundancy, and broad clinical versatility. Based on technology, analog platforms continue to serve legacy workflows and retrofit markets, but digital systems are leading new deployments due to superior image processing, integration capability, and enabling digital services. Understanding these segmentation vectors enables vendors and purchasers to align clinical performance expectations with procurement strategy and long-term service commitments.

A region-by-region perspective that explains how regulatory environments, infrastructure maturity, and local manufacturing shape C-arm adoption across global markets

Regional dynamics shape adoption pathways and commercial strategy, with variation driven by regulatory frameworks, healthcare delivery models, and manufacturing footprints. In the Americas, clinical demand is concentrated in large hospital networks and growing outpatient surgical centers, supported by established distribution channels and a strong emphasis on lifecycle service agreements. Reimbursement frameworks and capital approval processes in the region incentivize investments that deliver operational efficiencies and measurable clinical improvements, which in turn elevate interest in integrated imaging and software-enabled functionality.

In Europe, Middle East & Africa, heterogeneous regulatory regimes and variable infrastructure maturity create a patchwork of opportunity. Western Europe tends to adopt advanced imaging capabilities within tertiary hospitals and hybrid suites, while other regional markets prioritize durable, serviceable systems that can function reliably in constrained environments. Middle Eastern healthcare investment has driven demand for high-end imaging in flagship centers, whereas parts of Africa present long-term growth potential tied to investments in basic fluoroscopy and training infrastructure.

The Asia-Pacific region combines high-volume demand with strong local manufacturing and supply chain networks. Adoption is being propelled by expanding hospital capacity, the proliferation of outpatient surgical facilities, and competitive vendor landscapes that feature both global OEMs and agile regional manufacturers. In many Asia-Pacific markets, procurement decisions balance capital constraints with the need for robust service coverage, making locally supported service models and retrofit upgrade paths particularly valuable. Across regions, vendors that tailor deployment models, financing options, and service footprints to local regulatory and operational realities achieve stronger uptake and long-term customer retention.

Strategic company-level analysis describing product modularity, service differentiation, partnership strategies, and evolving commercial models that define vendor competitiveness

Corporate strategies among leading suppliers emphasize end-to-end value propositions that combine hardware, software, and service. Companies are investing in modular product architectures that accommodate detector upgrades and software enhancements over time, which helps extend device lifecycles and supports recurring revenue through maintenance and software licensing. Strategic partnerships with navigation, robotics, and analytics providers are increasingly common, enabling combined solutions that address complex procedural workflows and create differentiated clinical value.

Aftermarket service performance is a competitive battleground. Firms that offer predictive maintenance, remote diagnostics, and rapid spare-parts logistics sustain higher uptime and stronger client relationships. In response, some suppliers are expanding direct service footprints or partnering with regional service organizations to improve responsiveness. Additionally, pricing models are evolving: flexible financing, pay-per-use constructs for high-utilization environments, and bundled service contracts are being used to lower procurement barriers and align vendor incentives with clinical outcomes.

Emerging and regional players are competing on cost, localized support, and niche clinical fit, while incumbents defend through innovations in detector technology, software ecosystems, and proven clinical evidence. Mergers and strategic alliances within the broader imaging and interventional markets continue to reshape competitive positioning, with an emphasis on building comprehensive interventional ecosystems rather than singular product offerings.

Actionable strategic priorities for vendors and health systems to enhance supply resilience, accelerate technology migration, and monetize service and software capabilities

Industry leaders should prioritize several strategic initiatives to secure market position and accelerate clinical adoption. First, invest in supply chain resilience through multi-sourcing and regional assembly capabilities to reduce exposure to trade and tariff volatility. This approach should be complemented by transparent supplier mapping and contractual clauses that mitigate lead-time and cost uncertainty. Second, accelerate the transition to flat panel detector technology and software-enabled features that demonstrably improve image quality and dose efficiency, while offering retrofit paths for legacy installed bases to preserve customer relationships.

Third, adopt service-centric commercial models that emphasize uptime guarantees, remote diagnostics, and outcome-linked service agreements. Tying value to measurable operational and clinical metrics strengthens procurement conversations and supports longer-term revenue stability. Fourth, expand partnerships with navigation and analytics providers to embed imaging systems within broader procedural ecosystems, which increases switching costs and enhances clinical value. Fifth, tailor regional go-to-market approaches: offer financing and localized service packages in emerging markets, and prioritize integration and hybrid OR capability in centers of excellence.

Finally, invest in clinician education and training programs that reduce user variability and demonstrate clinical utility for new features. By combining technology investments with strong service models and clinician enablement, companies can differentiate on total cost of ownership, clinical throughput, and patient safety outcomes, translating product innovation into sustainable commercial advantage.

A transparent and rigorous mixed-methods research approach combining primary clinician and procurement interviews with secondary regulatory and technical source triangulation for robust insight validation

The research approach combined qualitative and quantitative techniques to ensure comprehensive and validated insights. Primary research included structured interviews and guided discussions with interventional physicians, radiology leaders, operating room managers, procurement officers, and service executives across a spectrum of acute care and ambulatory facilities. These conversations explored clinical requirements, procurement criteria, service expectations, and real-world usage patterns to ground technical and commercial observations in frontline experience.

Secondary research leveraged peer-reviewed clinical literature, regulatory approval documentation, patent filings, clinical trial registries, and publicly available company disclosures to contextualize technological trends and product development pathways. Secondary sources were triangulated with primary findings to validate technology adoption narratives and to identify areas of divergence between clinical expectations and vendor positioning. Data validation steps included cross-referencing interview input with documented product specifications and service offering descriptions, and circulating key findings to a panel of industry advisors for critique and refinement.

Limitations were acknowledged and addressed through targeted follow-up interviews and sensitivity checks. The methodology emphasized transparency in source attribution and reproducibility of analytic steps, enabling stakeholders to interrogate assumptions and adapt insights to their internal decision frameworks.

A concise conclusion tying together technology evolution, supply chain realities, and strategic imperatives for vendors and provider organizations in the C-arm space

In summary, C-arm systems sit at the intersection of clinical need, technological innovation, and operational constraint. The combined effects of detector modernization, software integration, and shifting procurement paradigms are reshaping how health systems and ambulatory providers evaluate imaging platforms. Tariff-driven supply chain shifts underscore the need for manufacturing agility and procurement transparency, while regional differences in regulation and infrastructure demand tailored commercialization strategies.

For clinical leaders and vendor executives, the imperative is clear: align product development with clinician workflows, ensure service models deliver predictable uptime, and present value in terms that resonate with capital planners and quality leaders. Vendors that marry hardware excellence with robust software ecosystems and flexible commercial terms will be better positioned to capture durable customer relationships. Meanwhile, providers that demand clarity on lifecycle support, integration capability, and proven clinical benefit will protect throughput and patient outcomes as adoption patterns evolve. The path forward favors strategic alignment between technology capability and operational reality, enabling safer, more efficient interventional care.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. C-arms Market, by System Type

  • 8.1. Fixed
  • 8.2. Mobile

9. C-arms Market, by Detector Type

  • 9.1. Flat Panel Detector
  • 9.2. Image Intensifier
    • 9.2.1. 12 Inch
    • 9.2.2. 16 Inch
    • 9.2.3. 9 Inch

10. C-arms Market, by Technology

  • 10.1. Analog
  • 10.2. Digital

11. C-arms Market, by Application

  • 11.1. Cardiology
  • 11.2. Emergency
  • 11.3. Gastroenterology
  • 11.4. Orthopedics
  • 11.5. Pain Management
  • 11.6. Urology
  • 11.7. Vascular Surgery

12. C-arms Market, by End User

  • 12.1. Ambulatory Surgical Centers
  • 12.2. Hospitals

13. C-arms Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. C-arms Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. C-arms Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States C-arms Market

17. China C-arms Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Airbus SE
  • 18.6. Aviation Industry Corporation of China, Ltd.
  • 18.7. BAE Systems plc
  • 18.8. China Aerospace Science and Industry Corporation Limited
  • 18.9. China Electronics Technology Group Corporation
  • 18.10. China North Industries Group Corporation Limited
  • 18.11. China State Shipbuilding Corporation Limited
  • 18.12. General Dynamics Corporation
  • 18.13. General Electric Company
  • 18.14. L3Harris Technologies, Inc.
  • 18.15. Leonardo S.p.A.
  • 18.16. Lockheed Martin Corporation
  • 18.17. Mitsubishi Heavy Industries, Ltd.
  • 18.18. Northrop Grumman Corporation
  • 18.19. Rheinmetall AG
  • 18.20. RTX Corporation
  • 18.21. Saab AB
  • 18.22. State Corporation Rostec
  • 18.23. Thales Group (Thales S.A.)
  • 18.24. The Boeing Company

LIST OF FIGURES

  • FIGURE 1. GLOBAL C-ARMS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL C-ARMS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL C-ARMS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL C-ARMS MARKET SIZE, BY SYSTEM TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL C-ARMS MARKET SIZE, BY DETECTOR TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL C-ARMS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL C-ARMS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL C-ARMS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL C-ARMS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL C-ARMS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL C-ARMS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES C-ARMS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA C-ARMS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL C-ARMS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL C-ARMS MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL C-ARMS MARKET SIZE, BY FIXED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL C-ARMS MARKET SIZE, BY FIXED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL C-ARMS MARKET SIZE, BY FIXED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL C-ARMS MARKET SIZE, BY MOBILE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL C-ARMS MARKET SIZE, BY MOBILE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL C-ARMS MARKET SIZE, BY MOBILE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL C-ARMS MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL C-ARMS MARKET SIZE, BY FLAT PANEL DETECTOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL C-ARMS MARKET SIZE, BY FLAT PANEL DETECTOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL C-ARMS MARKET SIZE, BY FLAT PANEL DETECTOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL C-ARMS MARKET SIZE, BY IMAGE INTENSIFIER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL C-ARMS MARKET SIZE, BY IMAGE INTENSIFIER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL C-ARMS MARKET SIZE, BY IMAGE INTENSIFIER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL C-ARMS MARKET SIZE, BY IMAGE INTENSIFIER, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL C-ARMS MARKET SIZE, BY 12 INCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL C-ARMS MARKET SIZE, BY 12 INCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL C-ARMS MARKET SIZE, BY 12 INCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL C-ARMS MARKET SIZE, BY 16 INCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL C-ARMS MARKET SIZE, BY 16 INCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL C-ARMS MARKET SIZE, BY 16 INCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL C-ARMS MARKET SIZE, BY 9 INCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL C-ARMS MARKET SIZE, BY 9 INCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL C-ARMS MARKET SIZE, BY 9 INCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL C-ARMS MARKET SIZE, BY ANALOG, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL C-ARMS MARKET SIZE, BY ANALOG, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL C-ARMS MARKET SIZE, BY ANALOG, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL C-ARMS MARKET SIZE, BY DIGITAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL C-ARMS MARKET SIZE, BY DIGITAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL C-ARMS MARKET SIZE, BY DIGITAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL C-ARMS MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL C-ARMS MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL C-ARMS MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL C-ARMS MARKET SIZE, BY EMERGENCY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL C-ARMS MARKET SIZE, BY EMERGENCY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL C-ARMS MARKET SIZE, BY EMERGENCY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL C-ARMS MARKET SIZE, BY GASTROENTEROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL C-ARMS MARKET SIZE, BY GASTROENTEROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL C-ARMS MARKET SIZE, BY GASTROENTEROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL C-ARMS MARKET SIZE, BY ORTHOPEDICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL C-ARMS MARKET SIZE, BY ORTHOPEDICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL C-ARMS MARKET SIZE, BY ORTHOPEDICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL C-ARMS MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL C-ARMS MARKET SIZE, BY PAIN MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL C-ARMS MARKET SIZE, BY PAIN MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL C-ARMS MARKET SIZE, BY UROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL C-ARMS MARKET SIZE, BY UROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL C-ARMS MARKET SIZE, BY UROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL C-ARMS MARKET SIZE, BY VASCULAR SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL C-ARMS MARKET SIZE, BY VASCULAR SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL C-ARMS MARKET SIZE, BY VASCULAR SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL C-ARMS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL C-ARMS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL C-ARMS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL C-ARMS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL C-ARMS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL C-ARMS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL C-ARMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. AMERICAS C-ARMS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 64. AMERICAS C-ARMS MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 65. AMERICAS C-ARMS MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 66. AMERICAS C-ARMS MARKET SIZE, BY IMAGE INTENSIFIER, 2018-2032 (USD MILLION)
  • TABLE 67. AMERICAS C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 68. AMERICAS C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 69. AMERICAS C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 70. NORTH AMERICA C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. NORTH AMERICA C-ARMS MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 72. NORTH AMERICA C-ARMS MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 73. NORTH AMERICA C-ARMS MARKET SIZE, BY IMAGE INTENSIFIER, 2018-2032 (USD MILLION)
  • TABLE 74. NORTH AMERICA C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 75. NORTH AMERICA C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 76. NORTH AMERICA C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 77. LATIN AMERICA C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. LATIN AMERICA C-ARMS MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 79. LATIN AMERICA C-ARMS MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 80. LATIN AMERICA C-ARMS MARKET SIZE, BY IMAGE INTENSIFIER, 2018-2032 (USD MILLION)
  • TABLE 81. LATIN AMERICA C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 82. LATIN AMERICA C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA C-ARMS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA C-ARMS MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA C-ARMS MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA C-ARMS MARKET SIZE, BY IMAGE INTENSIFIER, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE, MIDDLE EAST & AFRICA C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE C-ARMS MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE C-ARMS MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE C-ARMS MARKET SIZE, BY IMAGE INTENSIFIER, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 98. MIDDLE EAST C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. MIDDLE EAST C-ARMS MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. MIDDLE EAST C-ARMS MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 101. MIDDLE EAST C-ARMS MARKET SIZE, BY IMAGE INTENSIFIER, 2018-2032 (USD MILLION)
  • TABLE 102. MIDDLE EAST C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 103. MIDDLE EAST C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 104. MIDDLE EAST C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 105. AFRICA C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. AFRICA C-ARMS MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. AFRICA C-ARMS MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 108. AFRICA C-ARMS MARKET SIZE, BY IMAGE INTENSIFIER, 2018-2032 (USD MILLION)
  • TABLE 109. AFRICA C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 110. AFRICA C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 111. AFRICA C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC C-ARMS MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC C-ARMS MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC C-ARMS MARKET SIZE, BY IMAGE INTENSIFIER, 2018-2032 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL C-ARMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. ASEAN C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. ASEAN C-ARMS MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. ASEAN C-ARMS MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. ASEAN C-ARMS MARKET SIZE, BY IMAGE INTENSIFIER, 2018-2032 (USD MILLION)
  • TABLE 124. ASEAN C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 125. ASEAN C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 126. ASEAN C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 127. GCC C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. GCC C-ARMS MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. GCC C-ARMS MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. GCC C-ARMS MARKET SIZE, BY IMAGE INTENSIFIER, 2018-2032 (USD MILLION)
  • TABLE 131. GCC C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 132. GCC C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 133. GCC C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPEAN UNION C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPEAN UNION C-ARMS MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPEAN UNION C-ARMS MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPEAN UNION C-ARMS MARKET SIZE, BY IMAGE INTENSIFIER, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPEAN UNION C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPEAN UNION C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPEAN UNION C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 141. BRICS C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. BRICS C-ARMS MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. BRICS C-ARMS MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 144. BRICS C-ARMS MARKET SIZE, BY IMAGE INTENSIFIER, 2018-2032 (USD MILLION)
  • TABLE 145. BRICS C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 146. BRICS C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 147. BRICS C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 148. G7 C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 149. G7 C-ARMS MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. G7 C-ARMS MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. G7 C-ARMS MARKET SIZE, BY IMAGE INTENSIFIER, 2018-2032 (USD MILLION)
  • TABLE 152. G7 C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 153. G7 C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 154. G7 C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 155. NATO C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. NATO C-ARMS MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. NATO C-ARMS MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. NATO C-ARMS MARKET SIZE, BY IMAGE INTENSIFIER, 2018-2032 (USD MILLION)
  • TABLE 159. NATO C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 160. NATO C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 161. NATO C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 162. GLOBAL C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. UNITED STATES C-ARMS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 164. UNITED STATES C-ARMS MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. UNITED STATES C-ARMS MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. UNITED STATES C-ARMS MARKET SIZE, BY IMAGE INTENSIFIER, 2018-2032 (USD MILLION)
  • TABLE 167. UNITED STATES C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 168. UNITED STATES C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 169. UNITED STATES C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 170. CHINA C-ARMS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 171. CHINA C-ARMS MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. CHINA C-ARMS MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. CHINA C-ARMS MARKET SIZE, BY IMAGE INTENSIFIER, 2018-2032 (USD MILLION)
  • TABLE 174. CHINA C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 175. CHINA C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 176. CHINA C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)